Category Archives: J. CONDITIONS TO TREAT

Benefits of yoga in patients with heart disease

Stress is one of the most commonly reported risk factors for cardiovascular disease among the general public and among patients who have had a heart attack.

Now, a study of 33 adults concludes that 1.5 hours of yoga and meditation three times weekly for 6 weeks, with additional sessions at home, has benefits for people with heart disease.
Continue reading Benefits of yoga in patients with heart disease →

Wolfsbane: Uses, risks, and admonitions

“The wolfsbane I should dread;
Nor will I dreary rosemarye,
That always mourns the dead;
But I will woo the dainty rose,
With her cheeks of tender red.”
…Thomas Hood

Wolfsbane (Aconitum napellus, aconite, monkshood) is sometimes included in herbal remedies to treat inflammation, pain, musculoskeletal problems (eg arthritis), and heart problems. Continue reading Wolfsbane: Uses, risks, and admonitions →

Blood-sucking leeches treat osteoarthritis

Two reports from the University of Duisburg-Essen in Germany support the role of leeches (Hirudo medicinalis) to treat osteoarthritis of the knee. The first included 16 patients who, in addition to other treatments, received four medicinal leeches on the inflamed knee for 80 minutes. The response was compared to 6 patients given conventional pain treatment. The second study was of similar design in 51 patients.

Continue reading Blood-sucking leeches treat osteoarthritis →

Consumer alert: “Total Body Formula” and “Mega Formula”

The U.S. Food and Drug Administration advises not to purchase or consume Total Body Formula in the flavors of Tropical Orange and Peach Nectar, or Total Body Mega Formula in the Orange/Tangerine flavor.

There are 43 reports of people in 9 states who experienced serious adverse reactions. Continue reading Consumer alert: “Total Body Formula” and “Mega Formula” →

Making a case for an endocannabinoid deficiency

Dr. Ethan Russo (no relation) is a consultant for GW Pharmaceuticals and a proponent of medical marijuana.

This article is the latest justification that “migraine, fibromyalgia, irritable bowel syndrome, and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines.” Continue reading Making a case for an endocannabinoid deficiency →